Defining the potential for cell therapy for vascular disease using animal models

Rajiv Gulati, Robert D. Simari

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Cell-based therapeutics are currently being developed for a wide array of unmet medical needs. As obstructive vascular disease is the major cause of mortality in the world, cell-based strategies aimed at developing novel therapies or improving current therapies are currently under study. These studies are based on the evolving understanding of the biology of vascular progenitor cells, which has in turn led to the availability of well-defined sources of vascular cells for delivery. Crucial to the development of these approaches is the preclinical testing of cell delivery in animal models. This review highlights the crucial steps involved in the selection of cell sources and generation, delivery approaches, animal models to be used, and endpoints to be studied, in the context of cell delivery for vascular disease. Furthermore, the development of cell delivery to induce angiogenesis in ischemic limbs and to improve the response to large vessel injury will be discussed.

Original languageEnglish (US)
Pages (from-to)130-137
Number of pages8
JournalDMM Disease Models and Mechanisms
Volume2
Issue number3-4
DOIs
StatePublished - Mar 2009

Fingerprint

Cell- and Tissue-Based Therapy
Vascular Diseases
Animals
Animal Models
Availability
Testing
Blood Vessels
Stem Cells
Therapeutics
Extremities
Mortality
Wounds and Injuries

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine (miscellaneous)
  • Immunology and Microbiology (miscellaneous)
  • Neuroscience (miscellaneous)

Cite this

Defining the potential for cell therapy for vascular disease using animal models. / Gulati, Rajiv; Simari, Robert D.

In: DMM Disease Models and Mechanisms, Vol. 2, No. 3-4, 03.2009, p. 130-137.

Research output: Contribution to journalArticle

@article{4731a6a4479741e0a09f8a6f85ffd5ce,
title = "Defining the potential for cell therapy for vascular disease using animal models",
abstract = "Cell-based therapeutics are currently being developed for a wide array of unmet medical needs. As obstructive vascular disease is the major cause of mortality in the world, cell-based strategies aimed at developing novel therapies or improving current therapies are currently under study. These studies are based on the evolving understanding of the biology of vascular progenitor cells, which has in turn led to the availability of well-defined sources of vascular cells for delivery. Crucial to the development of these approaches is the preclinical testing of cell delivery in animal models. This review highlights the crucial steps involved in the selection of cell sources and generation, delivery approaches, animal models to be used, and endpoints to be studied, in the context of cell delivery for vascular disease. Furthermore, the development of cell delivery to induce angiogenesis in ischemic limbs and to improve the response to large vessel injury will be discussed.",
author = "Rajiv Gulati and Simari, {Robert D.}",
year = "2009",
month = "3",
doi = "10.1242/dmm.000562",
language = "English (US)",
volume = "2",
pages = "130--137",
journal = "DMM Disease Models and Mechanisms",
issn = "1754-8403",
publisher = "Company of Biologists Ltd",
number = "3-4",

}

TY - JOUR

T1 - Defining the potential for cell therapy for vascular disease using animal models

AU - Gulati, Rajiv

AU - Simari, Robert D.

PY - 2009/3

Y1 - 2009/3

N2 - Cell-based therapeutics are currently being developed for a wide array of unmet medical needs. As obstructive vascular disease is the major cause of mortality in the world, cell-based strategies aimed at developing novel therapies or improving current therapies are currently under study. These studies are based on the evolving understanding of the biology of vascular progenitor cells, which has in turn led to the availability of well-defined sources of vascular cells for delivery. Crucial to the development of these approaches is the preclinical testing of cell delivery in animal models. This review highlights the crucial steps involved in the selection of cell sources and generation, delivery approaches, animal models to be used, and endpoints to be studied, in the context of cell delivery for vascular disease. Furthermore, the development of cell delivery to induce angiogenesis in ischemic limbs and to improve the response to large vessel injury will be discussed.

AB - Cell-based therapeutics are currently being developed for a wide array of unmet medical needs. As obstructive vascular disease is the major cause of mortality in the world, cell-based strategies aimed at developing novel therapies or improving current therapies are currently under study. These studies are based on the evolving understanding of the biology of vascular progenitor cells, which has in turn led to the availability of well-defined sources of vascular cells for delivery. Crucial to the development of these approaches is the preclinical testing of cell delivery in animal models. This review highlights the crucial steps involved in the selection of cell sources and generation, delivery approaches, animal models to be used, and endpoints to be studied, in the context of cell delivery for vascular disease. Furthermore, the development of cell delivery to induce angiogenesis in ischemic limbs and to improve the response to large vessel injury will be discussed.

UR - http://www.scopus.com/inward/record.url?scp=69149111157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69149111157&partnerID=8YFLogxK

U2 - 10.1242/dmm.000562

DO - 10.1242/dmm.000562

M3 - Article

C2 - 19259386

AN - SCOPUS:69149111157

VL - 2

SP - 130

EP - 137

JO - DMM Disease Models and Mechanisms

JF - DMM Disease Models and Mechanisms

SN - 1754-8403

IS - 3-4

ER -